×
About 11,904 results

ALLMedicine™ Urticaria Center

Research & Reviews  4,573 results

Clinical Characteristics, Management, and Natural History of Chronic Inducible Urticari...
https://doi.org/10.1159/000514757
International Archives of Allergy and Immunology; Miles LM, Gabrielli S et. al.

Apr 1st, 2021 - Some forms of chronic urticaria (CU) can be specifically attributed to a response to a definite trigger, referred to as chronic inducible urticaria (CIndU). We aimed to assess the demographics, clinical characteristics, comorbidities, natural hist...

Characterization of Outpatient Visits and Treatments for Urticaria in the United States...
https://doi.org/10.1016/j.jaad.2021.03.067
Journal of the American Academy of Dermatology; Ugwu N, Cheraghlou S et. al.

Mar 28th, 2021 - Characterization of Outpatient Visits and Treatments for Urticaria in the United States Adult Population Between 1998 and 2016.|2021|Ugwu N,Cheraghlou S,Feng H,Cohen JM,|

Efficacy of omalizumab for extracutaneous symptoms of chronic spontaneous urticaria.
https://doi.org/10.1684/ejd.2020.3717
European Journal of Dermatology : EJD; Belbezier A, Boccon-Gibod I et. al.

Mar 27th, 2021 - Efficacy of omalizumab for extracutaneous symptoms of chronic spontaneous urticaria.|2021|Belbezier A,Boccon-Gibod I,Bouillet L,|

Markers for the involvement of endothelial cells and the coagulation system in chronic ...
https://doi.org/10.1111/all.14828
Allergy Mostmans Y, De Smedt K et. al.

Mar 26th, 2021 - Chronic urticaria (CU) is a chronic inflammatory mast cell-driven disorder. Endothelial cells (ECs)contribute importantly to key features of CU. Several markers of EC (dys)function in CU have been reported, but have not yet been systematically rev...

What is the contribution of IgE to nasal polyposis?
https://doi.org/10.1016/j.jaci.2021.03.016
The Journal of Allergy and Clinical Immunology; Bachert C, Maurer M et. al.

Mar 24th, 2021 - Taking a novel approach, this narrative review collates knowledge about nasal polyposis and the biological functions of IgE in several diseases (allergic rhinitis, allergic asthma, non-steroidal anti-inflammatory drugs-exacerbated respiratory dise...

see more →

Guidelines  27 results

Skin manifestations of COVID-19
https://www.ccjm.org/content/early/2020/05/12/ccjm.87a.ccc031
Cleveland Clinic Journal of Medicine; Young S, Fernandez AP.

May 13th, 2020 - Cutaneous manifestations, a well-known effect of viral infections, are beginning to be reported in patients with COVID-19 disease. These manifestations most often are morbilliform rash, urticaria, vesicular eruptions, acral lesions, and livedoid e...

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and ma...
https://doi.org/10.1111/all.13397
Allergy Zuberbier T, Aberer W et. al.

Jan 17th, 2018 - This evidence- and consensus-based guideline was developed following the methods recommended by Cochrane and the Grading of Recommendations Assessment, Development and Evaluation (GRADE) working group. The conference was held on 1 December 2016. I...

BSACI guideline for the management of chronic urticaria and angioedema.
https://doi.org/10.1111/cea.12494
Clinical and Experimental Allergy : Journal of the Britis... Powell RJ, Leech SC et. al.

Feb 25th, 2015 - This guidance for the management of patients with chronic urticaria and angioedema has been prepared by the Standards of Care Committee of the British Society for Allergy and Clinical Immunology (BSACI). The guideline is based on evidence as well ...

Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/...
https://doi.org/10.1111/all.12370
Allergy Zuberbier T, Aberer W et. al.

Jun 5th, 2014 - This methods report describes the process of guideline development in detail. It is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) methodology and a structured con...

The EAACI/GA(2) LEN/EDF/WAO Guideline for the definition, classification, diagnosis, an...
https://doi.org/10.1111/all.12313
Allergy Zuberbier T, Aberer W et. al.

May 2nd, 2014 - This guideline is the result of a systematic literature review using the 'Grading of Recommendations Assessment, Development and Evaluation' (GRADE) methodology and a structured consensus conference held on 28 and 29 November 2012, in Berlin. It i...

see more →

Drugs  1,125 results see all →

Clinicaltrials.gov  5,857 results

Clinical Characteristics, Management, and Natural History of Chronic Inducible Urticari...
https://doi.org/10.1159/000514757
International Archives of Allergy and Immunology; Miles LM, Gabrielli S et. al.

Apr 1st, 2021 - Some forms of chronic urticaria (CU) can be specifically attributed to a response to a definite trigger, referred to as chronic inducible urticaria (CIndU). We aimed to assess the demographics, clinical characteristics, comorbidities, natural hist...

Cyproheptadine hydrochloride - cyproheptadine hydrochloride tablet-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7e156e5e-e4cc-420b-8f1a-af123eaa9156

Mar 31st, 2021 - Perennial and seasonal allergic rhinitis Vasomotor rhinitis Allergic conjunctivitis due to inhalant allergens and foods Mild, uncomplicated allergic skin manifestations of urticarial and angioedema. Amelioration of allergic reactions to blood or p...

Promethazine hydrochloride - promethazine hydrochloride tablet-REMEDYREPACK INC.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=92152526-5094-4907-bd95-c182126778dc

Mar 29th, 2021 - Promethazine hydrochloride tablets, USP are useful for: Perennial and seasonal allergic rhinitis. Vasomotor rhinitis. Allergic conjunctivitis due to inhalant allergens and foods. Mild, uncomplicated allergic skin manifestations of urticaria and an...

Characterization of Outpatient Visits and Treatments for Urticaria in the United States...
https://doi.org/10.1016/j.jaad.2021.03.067
Journal of the American Academy of Dermatology; Ugwu N, Cheraghlou S et. al.

Mar 28th, 2021 - Characterization of Outpatient Visits and Treatments for Urticaria in the United States Adult Population Between 1998 and 2016.|2021|Ugwu N,Cheraghlou S,Feng H,Cohen JM,|

Efficacy of omalizumab for extracutaneous symptoms of chronic spontaneous urticaria.
https://doi.org/10.1684/ejd.2020.3717
European Journal of Dermatology : EJD; Belbezier A, Boccon-Gibod I et. al.

Mar 27th, 2021 - Efficacy of omalizumab for extracutaneous symptoms of chronic spontaneous urticaria.|2021|Belbezier A,Boccon-Gibod I,Bouillet L,|

see more →

News  305 results

Pressure Urticaria Can Mimic Physical Abuse
https://www.medscape.com/viewarticle/938263

Sep 29th, 2020 - NEW YORK (Reuters Health) - Pressure urticaria in an infant can be misdiagnosed as physical abuse, according to a case report. "While physicians and healthcare providers should be keen on screening for mistreatment, different presentations of skin...

Fast Five Quiz: Food Allergies
https://reference.staging.medscape.com/viewarticle/936716_3

Sep 7th, 2020 - Although anaphylaxis can occur without skin symptoms, cutaneous reactions are the most common clinical manifestations of an allergic reaction to a food or food additive. Peanuts remain the most common cause of severe food allergy symptoms and anap...

Fast Five Quiz: Chronic Spontaneous Urticaria
https://reference.medscape.com/viewarticle/920709_6

Jun 14th, 2020 - Answer 5/5 Which of the following treatment options is recommended for patients with severe CSU? Your peers chose: Combination antihistamine agents 0% Increasing the antihistamine dose 0% Switching to a different antihistamine 0% Prescribing a "co...

Fast Five Quiz: Chronic Spontaneous Urticaria
https://reference.medscape.com/viewarticle/920709_5

Jun 14th, 2020 - Both the American Academy of Allergy, Asthma, and Immunology (AAAAI) and the European Academy of Allergy and Clinical Immunology (EAACI)/Global Allergy and Asthma European Network (GA2LEN)/European Dermatology Forum (EDF)/World Allergy Organizatio...

Fast Five Quiz: Chronic Spontaneous Urticaria
https://reference.staging.medscape.com/viewarticle/920709_2

Jun 14th, 2020 - CSU, which has a global prevalence of 0.5%-5% of the general population, occurs more frequently in adult women than in adult men. The average peak age of onset of CSU is between 20 and 40 years. Learn more about the epidemiology of CSU.

see more →

Patient Education  17 results see all →